While North American cannabis markets are dominated by retail brands/products/consumers, the global cannabis industry is largely oriented to medical cannabis patients and treatments. In order to participate in this growing international medical opportunity, Licensed Cannabis cultivators and processors will be required to be certified to globally recognized pharmaceutical standards - Good Manufacturing Practices (GMP). Learn what’s involved in certifying and operating to GMP standards from a global leader.
Return to Speaker page
Tweet about it
Keith Strachan
President and Co-founder - MediPharm Labs
GMP Certification: The Gateway to the Global Cannabis Market
About Keith Strachan
Keith Strachan co-founded MediPharm Labs in 2015, utilizing his consultancy expertise in Public Sector RFP and government contracts, compliance for government licensing and local planning, to break the mold and secure the first Health Canada Licence for cannabis oil production without first being a cultivator. A seasoned entrepreneur, Keith has applied his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce, while also strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.
